These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 16955423

  • 1. Mirtazapine orally disintegrating tablets in depressed nursing home residents 85 years of age and older.
    Nelson JC, Hollander SB, Betzel J, Smolen P, Mirtazapine Nursing Home Study Group.
    Int J Geriatr Psychiatry; 2006 Sep; 21(9):898-901. PubMed ID: 16955423
    [Abstract] [Full Text] [Related]

  • 2. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.
    Roose SP, Nelson JC, Salzman C, Hollander SB, Rodrigues H, Mirtazapine in the Nursing Home Study Group.
    Curr Med Res Opin; 2003 Sep; 19(8):737-46. PubMed ID: 14687445
    [Abstract] [Full Text] [Related]

  • 3. Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study.
    Varia I, Venkataraman S, Hellegers C, Gersing K, Doraiswamy PM.
    Psychopharmacol Bull; 2007 Sep; 40(1):47-56. PubMed ID: 17285095
    [Abstract] [Full Text] [Related]

  • 4. Are there predictors of outcome in depressed elderly nursing home residents during treatment with mirtazapine orally disintegrating tablets?
    Nelson JC, Holden K, Roose S, Salzman C, Hollander SB, Betzel JV.
    Int J Geriatr Psychiatry; 2007 Oct; 22(10):999-1003. PubMed ID: 17447229
    [Abstract] [Full Text] [Related]

  • 5. Efficacy, tolerability, and preference of mirtazapine orally disintegrating tablets in depressed patients: a 17-week naturalistic study in Lithuania.
    Danileviciūte V, Sveikata A, Adomaitiene V, Gumbrevicius G, Fokas V, Sveikatiene R.
    Medicina (Kaunas); 2009 Oct; 45(10):778-84. PubMed ID: 19996664
    [Abstract] [Full Text] [Related]

  • 6. The effect of mirtazapine in patients with chronic pain and concomitant depression.
    Freynhagen R, Muth-Selbach U, Lipfert P, Stevens MF, Zacharowski K, Tölle TR, von Giesen HJ.
    Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597
    [Abstract] [Full Text] [Related]

  • 7. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K, Søgaard J, Martin S, Bäuml J, Ravindran AV, Agren H, Vester-Blokland ED.
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [Abstract] [Full Text] [Related]

  • 8. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS, Ng F, Berk M.
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [Abstract] [Full Text] [Related]

  • 9. Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study.
    Saiz-Ruiz J, Montes JM, Ibáñez A, Díaz M, Vicente F, Pelegrín C, Viñas R, Arias F, Carrasco JL, Ferrando L.
    Hum Psychopharmacol; 2005 Aug; 20(6):435-40. PubMed ID: 16106478
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A, Crawford GM, Angus M, Wilson R, Hamilton L.
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [Abstract] [Full Text] [Related]

  • 11. Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study.
    Yoon SJ, Pae CU, Kim DJ, Namkoong K, Lee E, Oh DY, Lee YS, Shin DH, Jeong YC, Kim JH, Choi SB, Hwang IB, Shin YC, Cho SN, Lee HK, Lee CT.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1196-201. PubMed ID: 16624467
    [Abstract] [Full Text] [Related]

  • 12. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
    Smith WT, Glaudin V, Panagides J, Gilvary E.
    Psychopharmacol Bull; 1990 Sep 30; 26(2):191-6. PubMed ID: 2236455
    [Abstract] [Full Text] [Related]

  • 13. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
    Honig A, Kuyper AM, Schene AH, van Melle JP, de Jonge P, Tulner DM, Schins A, Crijns HJ, Kuijpers PM, Vossen H, Lousberg R, Ormel J, MIND-IT investigators.
    Psychosom Med; 2007 Sep 30; 69(7):606-13. PubMed ID: 17846258
    [Abstract] [Full Text] [Related]

  • 14. Mirtazapine treatment of generalized anxiety disorder: a fixed dose, open label study.
    Gambi F, De Berardis D, Campanella D, Carano A, Sepede G, Salini G, Mezzano D, Cicconetti A, Penna L, Salerno RM, Ferro FM.
    J Psychopharmacol; 2005 Sep 30; 19(5):483-7. PubMed ID: 16166185
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.
    Kim SW, Shin IS, Kim JM, Kim YC, Kim KS, Kim KM, Yang SJ, Yoon JS.
    Psychiatry Clin Neurosci; 2008 Feb 30; 62(1):75-83. PubMed ID: 18289144
    [Abstract] [Full Text] [Related]

  • 16. Mirtazapine naturalistic depression study (in Sweden)--MINDS(S): clinical efficacy and safety.
    Wålinder J, Prochazka J, Odén A, Sjödin I, Dahl ML, Ahlner J, Bengtsson F.
    Hum Psychopharmacol; 2006 Apr 30; 21(3):151-8. PubMed ID: 16444795
    [Abstract] [Full Text] [Related]

  • 17. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
    van Moffaert M, de Wilde J, Vereecken A, Dierick M, Evrard JL, Wilmotte J, Mendlewicz J.
    Int Clin Psychopharmacol; 1995 Mar 30; 10(1):3-9. PubMed ID: 7622801
    [Abstract] [Full Text] [Related]

  • 18. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
    Koran LM, Gamel NN, Choung HW, Smith EH, Aboujaoude EN.
    J Clin Psychiatry; 2005 Apr 30; 66(4):515-20. PubMed ID: 15816795
    [Abstract] [Full Text] [Related]

  • 19. Mirtazapine in the treatment of adolescents with major depression: an open-label, multicenter pilot study.
    Haapasalo-Pesu KM, Vuola T, Lahelma L, Marttunen M.
    J Child Adolesc Psychopharmacol; 2004 Apr 30; 14(2):175-84. PubMed ID: 15319015
    [Abstract] [Full Text] [Related]

  • 20. Onset of antidepressant action: a pharmacological question?
    Rojo JE, Gibert K, Cobo J, Rodriguez-Cano E, Vallejo J.
    Hum Psychopharmacol; 2005 Aug 30; 20(6):425-33. PubMed ID: 16106477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.